Trophoblastic Tumor Placental SiteSymptoms, Doctors, Treatments, Advances & More
Learn About Trophoblastic Tumor Placental Site
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Wei-Chien M. Lin, MD Private Practice
Wei-chien Lin is an Oncologist and an Obstetrics and Gynecologist practicing medicine in Mission Hills, California. Dr. Lin is rated as an Advanced provider by MediFind in the treatment of Trophoblastic Tumor Placental Site. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Malignant Mixed Mullerian Tumor, Cervical Cancer, Oophorectomy, and Salpingo-Oophorectomy. Dr. Lin is board certified in OB & Gyn (Sub: Gynecologic Oncology) and Obstetrics & Gynecology. Dr. Lin is currently accepting new patients.
Franciscan Medical Group
Maria Celeste-Lomarda is a primary care provider, practicing in Family Medicine in University Place, Washington. Dr. Celeste-Lomarda is rated as an Experienced provider by MediFind in the treatment of Trophoblastic Tumor Placental Site. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Hidradenitis Suppurativa, Type 2 Diabetes (T2D), Vertigo, and Osteomyelitis in Children. Dr. Celeste-Lomarda is currently accepting new patients.
Joshua Cohen is an Oncologist practicing medicine in Anchorage, California. Dr. Cohen is rated as an Advanced provider by MediFind in the treatment of Trophoblastic Tumor Placental Site. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Malignant Mixed Mullerian Tumor, Hernia Surgery, and Lymphadenectomy. Dr. Cohen is currently accepting new patients.
Summary: The purpose of this study is to establish a prospective, single-center platform research based on clinical subtypes to explore precision neoadjuvant therapy in patients with operable breast cancer who met the indications for neoadjuvant chemotherapy and by the update of basic translational research in the center, especially the refinement of typing, the discovery of new targets and the development...